275 related articles for article (PubMed ID: 31527315)
1. IRAK4 mediates colitis-induced tumorigenesis and chemoresistance in colorectal cancer.
Li Q; Chen Y; Zhang D; Grossman J; Li L; Khurana N; Jiang H; Grierson PM; Herndon J; DeNardo DG; Challen GA; Liu J; Ruzinova MB; Fields RC; Lim KH
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31527315
[TBL] [Abstract][Full Text] [Related]
2. Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma.
Zhang D; Li L; Jiang H; Knolhoff BL; Lockhart AC; Wang-Gillam A; DeNardo DG; Ruzinova MB; Lim KH
Clin Cancer Res; 2017 Apr; 23(7):1748-1759. PubMed ID: 27702822
[No Abstract] [Full Text] [Related]
3. IRAK4 kinase activity controls Toll-like receptor-induced inflammation through the transcription factor IRF5 in primary human monocytes.
Cushing L; Winkler A; Jelinsky SA; Lee K; Korver W; Hawtin R; Rao VR; Fleming M; Lin LL
J Biol Chem; 2017 Nov; 292(45):18689-18698. PubMed ID: 28924041
[TBL] [Abstract][Full Text] [Related]
4. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell type-specific manner.
Cushing L; Stochaj W; Siegel M; Czerwinski R; Dower K; Wright Q; Hirschfield M; Casanova JL; Picard C; Puel A; Lin LL; Rao VR
J Biol Chem; 2014 Apr; 289(15):10865-10875. PubMed ID: 24567333
[TBL] [Abstract][Full Text] [Related]
6. IRAK4 in TLR/IL-1R signaling: possible clinical applications.
Li X
Eur J Immunol; 2008 Mar; 38(3):614-8. PubMed ID: 18286571
[TBL] [Abstract][Full Text] [Related]
7. A coding IRAK2 protein variant compromises Toll-like receptor (TLR) signaling and is associated with colorectal cancer survival.
Wang H; Flannery SM; Dickhöfer S; Huhn S; George J; Kubarenko AV; Lascorz J; Bevier M; Willemsen J; Pichulik T; Schafmayer C; Binder M; Manoury B; Paludan SR; Alarcon-Riquelme M; Bowie AG; Försti A; Weber ANR
J Biol Chem; 2014 Aug; 289(33):23123-23131. PubMed ID: 24973222
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide-modulated glioma proteome: role of interleukin-1 receptor-associated kinase-4 (IRAK4) in chemosensitivity.
Kumar DM; Patil V; Ramachandran B; Nila MV; Dharmalingam K; Somasundaram K
Proteomics; 2013 Jul; 13(14):2113-24. PubMed ID: 23595970
[TBL] [Abstract][Full Text] [Related]
9. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.
Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X
Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057
[TBL] [Abstract][Full Text] [Related]
10. A Novel IRAK4 Inhibitor DW18134 Ameliorates Peritonitis and Inflammatory Bowel Disease.
Huang Y; Ning Y; Chen Z; Song P; Tang H; Shi W; Wan Z; Huang G; Liu Q; Chen Y; Zhou Y; Li Y; Zhan Z; Ding J; Duan W; Xie H
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675622
[TBL] [Abstract][Full Text] [Related]
11. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity.
Kim TW; Staschke K; Bulek K; Yao J; Peters K; Oh KH; Vandenburg Y; Xiao H; Qian W; Hamilton T; Min B; Sen G; Gilmour R; Li X
J Exp Med; 2007 May; 204(5):1025-36. PubMed ID: 17470642
[TBL] [Abstract][Full Text] [Related]
12. Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy.
Kelly PN; Romero DL; Yang Y; Shaffer AL; Chaudhary D; Robinson S; Miao W; Rui L; Westlin WF; Kapeller R; Staudt LM
J Exp Med; 2015 Dec; 212(13):2189-201. PubMed ID: 26621451
[TBL] [Abstract][Full Text] [Related]
13. Deficiency in IRAK4 activity attenuates manifestations of murine Lupus.
Murphy M; Pattabiraman G; Manavalan TT; Medvedev AE
Eur J Immunol; 2017 May; 47(5):880-891. PubMed ID: 28295231
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of IRAK4 kinase activity improves ethanol-induced liver injury in mice.
Wang H; Zhou H; Zhang Q; Poulsen KL; Taylor V; McMullen MR; Czarnecki D; Dasarathy D; Yu M; Liao Y; Allende DS; Chen X; Hong L; Zhao J; Yang J; Nagy LE; Li X
J Hepatol; 2020 Dec; 73(6):1470-1481. PubMed ID: 32682051
[TBL] [Abstract][Full Text] [Related]
15. Modified apple polysaccharides suppress the migration and invasion of colorectal cancer cells induced by lipopolysaccharide.
Zhang D; Li YH; Mi M; Jiang FL; Yue ZG; Sun Y; Fan L; Meng J; Zhang X; Liu L; Mei QB
Nutr Res; 2013 Oct; 33(10):839-48. PubMed ID: 24074742
[TBL] [Abstract][Full Text] [Related]
16. miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axis.
Zhao C; Zhao Q; Zhang C; Wang G; Yao Y; Huang X; Zhan F; Zhu Y; Shi J; Chen J; Yan F; Zhang Y
Sci Rep; 2017 Jun; 7(1):4194. PubMed ID: 28646148
[TBL] [Abstract][Full Text] [Related]
17. Cloning and functional characterization of IRAK4 in large yellow croaker (Larimichthys crocea) that associates with MyD88 but impairs NF-κB activation.
Zou PF; Huang XN; Yao CL; Sun QX; Li Y; Zhu Q; Yu ZX; Fan ZJ
Fish Shellfish Immunol; 2017 Apr; 63():452-464. PubMed ID: 27989863
[TBL] [Abstract][Full Text] [Related]
18. Phospholipase Cϵ Activates Nuclear Factor-κB Signaling by Causing Cytoplasmic Localization of Ribosomal S6 Kinase and Facilitating Its Phosphorylation of Inhibitor κB in Colon Epithelial Cells.
Wakita M; Edamatsu H; Li M; Emi A; Kitazawa S; Kataoka T
J Biol Chem; 2016 Jun; 291(24):12586-12600. PubMed ID: 27053111
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling.
Wang D; Yang L; Yu W; Wu Q; Lian J; Li F; Liu S; Li A; He Z; Liu J; Sun Z; Yuan W; Zhang Y
J Immunother Cancer; 2019 Aug; 7(1):215. PubMed ID: 31395078
[TBL] [Abstract][Full Text] [Related]
20. IRAK4 as a molecular target in the amelioration of innate immunity-related endotoxic shock and acute liver injury by chlorogenic acid.
Park SH; Baek SI; Yun J; Lee S; Yoon DY; Jung JK; Jung SH; Hwang BY; Hong JT; Han SB; Kim Y
J Immunol; 2015 Feb; 194(3):1122-30. PubMed ID: 25548221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
